Sanjeev Pathak MD

Psychiatry•Wilmington, DE

Child & Adolescent Psychiatry

Psychiatrist

Join to View Full Profile

825 Washington StWilmington, DE 19801
Phone+1 302-655-7110
Fax+1 302-655-6185

Education & Training

Cincinnati Children's Hospital Medical CenterFellowship, Child and Adolescent Psychiatry, 1999 - 2001
University of Cincinnati Medical Center/College of MedicineResidency, Psychiatry, 1996 - 1999
All India Institute of Medical SciencesClass of 1992

Certifications & Licensure

OH State Medical License 1999 - 2026
DE State Medical License 2010 - 2015

Clinical Trials

A Study of Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD) Start of enrollment: 2014 Feb 01
Completed
Phase 3
A Long-Term Safety Study of ALKS 5461 Start of enrollment: 2014 May 01
Completed
Phase 3
A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 Study Start of enrollment: 2014 May 01
Completed
Phase 3
A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 Study Start of enrollment: 2014 May 01
Completed
Phase 3
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder Start of enrollment: 2014 May 01
Completed
Phase 2
A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - FORWARD-5 Study Start of enrollment: 2014 Jul 01
Completed
Phase 3
A Study of the Abuse Liability Potential of Samidorphan in Healthy, Non-Dependent, Recreational Opioid Users Start of enrollment: 2014 Aug 01
Completed
Phase 1
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia Start of enrollment: 2017 Nov 15
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

5 citations
Pimavanserin for psychosis in Parkinson's disease dementia: Subgroup analysis of the HARMONY Trial.
Daniel Weintraub, Alberto J Espay, Vibhash D Sharma, Pierre N Tariot, Victor Abler
Parkinsonism & Related Disorders. 2024-02-01
Challenges and proposed solutions to conducting Alzheimer's disease psychosis trials.
Clive Ballard, Pierre Tariot, Maria Soto-Martin, Sanjeev Pathak, I-Yuan Liu
Frontiers in Psychiatry. 2024-01-01
51 citations
Opioid system modulation with buprenorphine/samidorphan combination for major depressive disorder: two randomized controlled studies.
Maurizio Fava, Michael E. Thase, Madhukar H. Trivedi, Elliot Ehrich, William F. Martin
Molecular Psychiatry. 2020-07-01

Authored Content

S99. Evaluation of Abuse Potential of Samidorphan in Healthy, Nondependent, Recreational Opioid UsersApril 2018
S99. Evaluation of Abuse Potential of Samidorphan in Healthy, Nondependent, Recreational Opioid UsersApril 2018